Background—A rapidly growing number of long-QT syndrome (LQTS) patients are being
treated with an implantable cardioverter-defibrillator (ICD). ICDs may pose problems …

Introduction: Implantable cardioverter defibrillators (ICDs) are increasingly being used in
highrisk long QT syndrome (LQTS) patients, but there are limited data regarding clinical …

OBJECTIVES: The purpose of this study was to evaluate retrospectively a single-center
experience with the use of ICDs in patients with long QT syndrome (LQTS) concerning …

BACKGROUND: Long QT syndrome's (LQTS) marked heterogeneity necessitates both
evidence-based and individualized therapeutic approaches. OBJECTIVE: This study sought …

Objectives: We sought to assess the spectrum and outcome of young long QT syndrome
(LQTS) patients, addressing treatment including device indications, risks, and benefits …

The long QT syndrome (LQTS) is a genetic disorder characterized by prolongation of the QT
interval in the electrocardiogram (ECG) and a propensity to torsades de pointes ventricular …

Abstract Background: Long QT syndrome (LQTS) is a potentially lethal cardiac
channelopathy with a 1% to 5% annual risk of LQTS-triggered syncope, aborted cardiac …

Aims Risk stratification of patients with long QT syndrome (LQTS) represents a difficult task.
In 2018, we proposed a granular estimate of the baseline 5-year risk of life-threatening …

Long QT syndrome (LQT) represents a heterogeneous family of cardiac electrophysiologic
disorders characterized by QT prolongation and T-wave abnormalities on the …

The hereditary Long QT syndrome (LQTS) is a genetic channelopathy with variable
penetrance that is associated with increased propensity for polymorphic ventricular …